Recipharm signs manufacturing agreement with Enzymatica
Recipharm, a leading contract development and manufacturing organisation (CDMO) and Enzymatica, a Swedish life science company specialising in products with a protective barrier, have signed a broadened contract for the manufacture of ColdZyme®. The agreement will involve an additional Recipharm production site in Pianezza, Italy, to support Enzymatica in increasing production volumes of ColdZyme to meet growing global demand. Both the facilities in Parets, Spain, and Pianezza, Italy, will be making additional investments to accommodate requirements moving forward. Kenth Berg, Vice